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Subdermal plexus skin flaps, also known as local or random pattern flaps, may be used to reconstruct 
skin defects in dogs and cats when primary closure 
is not possible. Relatively simple to perform, an SPSF 
procedure may be preferred when a choice exists 
between that and a more advanced reconstructive 
technique, such as axial pattern flap or free-skin graft 
procedures. Unlike axial pattern flaps, SPSFs do not 
contain a specific or named direct cutaneous artery 
and instead derive their blood supply from the ter-
minal branches of cutaneous trunci vessels in the 
subdermal plexus, which run from the base of the 
flap. However, in some anatomic areas, the wider 
the base of the SPSF, the greater the chance of ac-
cidentally incorporating part of an adjacent direct 
cutaneous artery.1,2
Subdermal plexus skin flaps can be classified ac-
cording to their location relative to the skin deficit 
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OBJECTIVE
To describe indications, complications, and outcomes associated with sub-
dermal plexus skin flap (SPSF) procedures in dogs and cats.
ANIMALS
53 dogs and 20 cats that received SPSFs for reconstruction of skin defects 
from 2000 to 2017.
PROCEDURES
Medical record data were collected and summarized regarding patient sig-
nalment, indication for the SPSF procedure, type and location of SPSF, com-
plications, and outcome.
RESULTS
92 SPSF procedures (64 in dogs and 28 in cats) were included. Indications 
for the procedures included tumor excision (n = 37 [40%]), acute wound 
(14 [15%]) or chronic wound (28 [30%]) reconstruction, surgical scar revi-
sion (7 [8%]), and other reasons (6 [7%]). Types of SPSFs included advance-
ment (31 [34%]), axillary fold (20 [22%]), inguinal fold (20 [22%]), rotation 
(16 [17%]), transposition (3 [3%]), and distant direct (2 [2%]). Complica-
tions were noted for 47 (51%) procedures at a mean ± SD of 6.9 ± 4.0 days 
after surgery and were classified as minor (34 [37%]) or major (13 [14%]). 
Outcome was considered excellent for 44 (48%) procedures, good for 33 
(36%), fair for 13 (14%), and poor for 2 (2%).
CONCLUSIONS AND CLINICAL RELEVANCE
Results suggested that approximately half of SPSF procedures in dogs and 
cats can be expected to be followed by a complication, occurring at a mean 
of 1 week after surgery, and yet with appropriate management of these 
complications, a good to excellent outcome was possible. Owners should 
be counseled about the likely need for additional visits and costs associ-
ated with treatment of postoperative complications. ( J Am Vet Med Assoc 
2019;255:933–938)
and method of transfer, such as advancement, rota-
tion, transposition, axillary fold, and inguinal fold 
flaps.1–3 Distant direct SPSFs can also be created and 
are most commonly used to cover skin deficits on the 
proximal and middle aspects of a limb.2,4
Because dogs and cats generally have loose skin, 
SPSFs are commonly available and used; neverthe-
less, little information has been published regarding 
indications, complications, and outcomes associated 
with SPSF procedures, and the limited available infor-
mation is based on studies involving small numbers 
of animals or case reports. For example, in a study5 
involving dogs that received an SPSF to close the 
skin deficit created by tumor excision, no difference 
in flap survival rate was identified between dogs in 
which nonabsorbable suture was used (n = 10) and 
those in which nonabsorbable suture and cyanoacry-
late adhesive were used (5). The mean flap survival 
rate for the 2 groups was 85%. In another study,6 axil-
lary and inguinal fold flaps were used in 6 dogs and 
2 cats. Two of the 6 dogs had complications, and all 
patients had a successful outcome. A case series4 of 
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distant direct SPSF procedures performed at 5 insti-
tutions revealed a 95% flap survival rate for 12 of 14 
animals (10 dogs and 4 cats), and infection and dehis-
cence were the most common complications.
To the authors’ knowledge, no large-scale study has 
been performed on the use of SPSFs in cats and dogs or 
the use and outcome of SPSFs for the reconstruction of 
acute or chronic wounds, as opposed to the reconstruc-
tion of surgical wounds following tumor excision. The 
aim of the study reported here was to describe the in-
dications, complications, and outcomes associated with 
various types of SPSFs used to reconstruct skin deficits 
of various causes in a large number of dogs and cats.
Materials and Methods
Case selection criteria
Electronic medical records at the Queen Moth-
er Hospital for Animals, University of London, were 
searched to identify dogs and cats that received an 
SPSF between January 1, 2000, and December 31, 
2017, for treatment of a skin defect. Patients receiving 
a flap that included muscle layers other than the pan-
niculus (eg, a latissimus dorsi myocutaneous advance-
ment flap) or a direct cutaneous artery (ie, an axial 
pattern flap) were excluded.
Medical records review
For each dog and cat included in the study, in-
formation was retrieved from the medical record re-
garding patient signalment, indication for the SPSF 
procedure, type and location of SPSF, perioperative 
management details (including antimicrobial treat-
ment), complications, and outcome. For patients that 
received multiple SPSFs, the details and outcome of 
each SPSF procedure were recorded separately.
Chronic wounds were defined as those that had 
failed previous wound treatments or surgeries before 
patients were referred to the study hospital for further 
assessment and surgery. Acute wounds were defined as 
traumatic wounds in patients evaluated by the hospital’s 
emergency service that had been transferred directly for 
surgical assessment without failing any previous wound 
management. Scar revision surgery was considered to 
have been performed when biopsy results for excised 
tumors indicated that that the margins were not clean, 
and a second surgery was performed in an attempt to 
create clean margins.
Complications affecting the SPSF within the post-
operative period until the point of discharge from 
the hospital were recorded, as were any wound com-
plications noted at subsequent visits to the hospital. A 
complication was classified as major if a second SPSF 
procedure was required or > 50% of the SPSF under-
went necrosis and sloughing (ie, > 50% flap failure). All 
other complications were classified as minor, including 
seroma, wound discharge, wound infection treatable 
with appropriate antimicrobials and wound manage-
ment, and dehiscence of small portions of the flap suc-
cessfully managed by second-intention healing, none 
of which prevented the SPSF from healing successfully. 
Such complications also included wounds that required 
the patient to be sedated for wound debridement and 
lavage to facilitate successful healing.
Outcome was defined by use of previously report-
ed criteria7 as excellent (no complications), good (with 
complications that required minimal intervention and 
healed successfully by second intention), fair (with 
complications that required a second surgery to achieve 
successful closure), or poor (with complications that re-
quired > 1 additional surgical intervention or involved 
irredeemable sloughing and necrosis of the flap).
SPSF procedures
Patients with wounds were managed until a healthy 
bed of granulation tissue filled the skin defect before 
wound reconstruction with an SPSF was attempted. Sur-
gically created skin deficits, such as those created by tu-
mor excision, were closed with an SPSF immediately af-
ter creation during the same surgical procedure. All SPSF 
procedures were performed as described elsewhere.1–4
Statistical analysis
Data were analyzed with the aid of statistical 
software.a Continuous data (eg, patient age) were evalu-
ated for normality of distribution with the D’Agostino-
Pearson normality test; normally distributed data were 
reported as mean ± SD, and nonnormally distributed data 
were reported as median (range). Categorical data were 
compared between selected groups by means of the χ2 
test or, when a given category was represented by < 5 
observations, the Fisher exact test. The null hypothesis 
for all statistical tests was homogeneity between groups, 
and values of P < 0.05 were considered significant.
Results
Animals
Fifty-three dogs with a mean ± SD age of 7.0 ± 3.3 
years were included in the study. Dogs were classified as 
Labrador Retriever (n = 53 [13%]), Boxer (5 [9%]), Cocker 
Spaniel (4 [8%]), or other breeds (≤ 3 each) or as a mixed-
breed dog (4 [8%]). Twenty-three (43%) dogs were neu-
tered females, 14 (26%) were neutered males, 11 (21%) 
were sexually intact males, and 5 (9%) were sexually in-
tact females. These 53 dogs received 64 SPSFs that met 
the inclusion criteria: 1 (2%) dog had 4 flaps, 2 (4%) had 3 
flaps, 4 (8%) had 2 flaps, and 46 (87%) had 1 flap.
Twenty cats with a median age of 4.5 years (range, 
0.5 to 17 years) were also included. Cats were classified as 
domestic shorthair (n = 16 [80%]) as well as Maine Coon, 
Siamese, Siamese-cross, and Bengal (1 [5%] each). Ten 
(50%) cats were neutered males, 8 (40%) were neutered 
females, 1 (5%) was a sexually intact male, and 1 (5%) 
was a sexually intact female. These 20 cats received 28 
SPSFs that met the inclusion criteria: 2 (10%) cats had 3 
flaps, 4 (20%) had 2 flaps, and 14 (70%) had 1 flap.
SPSFs
Indications for SPSF procedures for dogs and cats 
combined included tumor excision (n = 37 [40%]), acute 
wound (14 [15%]) or chronic wound (28 [30%]) recon-
Small Animals
 JAVMA  |  OCT 15, 2019  |  VOL 255  |  NO. 8 935
struction, surgical scar revision after incomplete tumor 
removal (7 [8%]), and other reasons (6 [7%]). Other rea-
sons included lip-fold dermatitis (2 [2%]), herpes derma-
titis (2 [2%]), corn removal (1 [1%]), and fungal mass re-
moval (1 [1%]). Location of the SPSFs included the torso 
(43 [47%]), proximal aspect of a limb (29 [32%]), head or 
face (18 [20%]), and distal aspect of a limb (2 [2%]).
The types of SPSFs used to reconstruct the recipi-
ent skin deficit in dogs and cats combined included ad-
vancement (n = 31 [34%]), axillary fold (20 [22%]), in-
guinal fold (20 [22%]), rotation (16 [17%]), transposition 
(3 [3%]), and distant direct (2 [2%]). Nineteen of the 64 
(30%) flaps in dogs were the advancement type (includ-
ing 1 vulval skin advancement flap), 18 (28%) were the 
axillary fold type, 12 (29%) were the inguinal fold type, 
10 (16%) were the rotation type (including 1 scrotal skin 
rotation flap performed immediately after castration), 3 
(5%) were the transposition type, and 2 (3%) were the 
distant direct type. In cats, 12 of the 28 (43%) SPSFs were 
the advancement type, 8 (29%) were the inguinal fold 
type, 6 (21%) were the rotation type, and 2 (7%) were 
the axillary fold type (1 of which was also omentalized).
An active suction drain was placed at surgery in 
10 of the 92 (11%) flaps and a passive drain in 24 (26%) 
flaps, according to surgeon preference. For 1 rotation 
flap, negative-pressure wound therapy was applied for 
3 days after surgery to help maintain distal tip viability.
Broad-spectrum antimicrobials (cefuroximeb or 
amoxicillin–clavulanic acidc; 10 mg/kg [22 mg/lb], IV, 
q 2 h) were administered from the point of anesthetic 
induction until surgery concluded for 36 (39%) SPSF pro-
cedures on the basis of the class and duration of surgery.
Postoperative complications
Postoperative complications were recorded for 
47 of the 92 (51%) SPSF procedures, and some proce-
dures resulted in > 1 complication. Data regarding the 
first signs of a complication were available for 34 SPSF 
procedures with complications, and the mean ± SD 
number of days for a complication to be noted was 6.9 
± 4.0. Observed complications included dehiscence 
of the distal wound edge (n = 28 [30%]), seroma (11 
[12%]), partial flap failure due to necrosis or sloughing 
(9 [10%]), infection (8 [9%]), discharge (4 [4%]), ulcer-
ation (2 [2%]), and self-trauma (1 [1%]). Ulceration was 
believed to have occurred in 1 dog because the SPSF 
was in contact with a canine tooth and in 1 cat because 
of herpesvirus infection. Overall, these complications 
were considered minor for 34 (37%) procedures and 
major (requiring second surgery or > 50% flap failure) 
for 13 (14%) procedures.
For the 8 patients with a postoperative infection, 
amoxicillin–clavulanic acid was administered PO on 
an empirical basis for 7 to 14 days until results of bacte-
rial culture and antimicrobial susceptibility tests could 
be obtained, and this course of treatment was complet-
ed or changed to an appropriate oral antimicrobial for-
mulation as indicated by the susceptibility test results. 
The 2 cats with a postoperative infection received the 
SPSF for treatment of an acute wound, whereas 3 of 
the 6 dogs with a postoperative infection received the 
SPSF for treatment of a chronic wound and the remain-
ing 3 were undergoing tumor excision.
In dogs, 35 of the 64 (55%) SPSF procedures resulted 
in complications, of which 25 (39%) were classified as 
minor and 10 (16%) as major. In cats, 12 of the 28 (43%) 
SPSF procedures resulted in complications, of which 9 
(32%) were classified as minor and 3 (11%) as major. No 
significant (P = 0.51) difference in overall complication 
rate was identified between dogs and cats.
Complications and complication rates associated 
with the different types of, indications for, and locations 
of SPSFs were summarized for dogs and cats combined 
(Tables 1–3). Inguinal fold flaps, axillary fold flaps, 
rotation flaps, and 2 distant direct flaps had the high-
est complication rates, whereas advancement flaps and 
transposition flaps had the lowest complication rates. 
The large number of SPSF types and small numbers 
within some of the groups precluded statistical compar-
ison of complication rates among types of SPSFs. The 
overall complication rate for SPSFs used to reconstruct 
acute or chronic wounds was significantly (P = 0.005) 
higher than that for SPSFs used to reconstruct a tumor 
excision deficit or scar revision deficit. No significant (P 
= 0.35) difference in overall complication rate was iden-
tified between flaps used to reconstruct acute wounds 
and those used to reconstruct chronic wounds.
The overall complication rates for SPSFs used to 
reconstruct skin deficits of the torso (P = 0.02) and 
proximal aspect of a limb (P < 0.001) were signifi-
cantly higher than the rate for SPSFs used on the head 
or face. No significant (P = 0.14) difference in overall 
complication rate was identified between SPSFs used 
to reconstruct proximal limb versus torso skin defects.
 Total complications Minor complication Major complication
Type of SPSF (n = 47) (n = 34) (n = 13)
Advancement (n = 31) 7 (23) 5 (16) 2 (6)
Inguinal fold (n = 20) 13 (65) 9 (45) 4 (10)
Axillary fold (n = 20) 15 (75) 10 (50) 5 (15)
Rotation (n = 16) 9 (56) 9 (56) 0 (0)
Transposition (n = 3) 1 (33) 0 (0) 1 (33)
Distant direct (n = 2) 2 (100) 1 (50) 1 (50)
Data represent number (%) of each type of SPSF with a complication.
Table 1—Complications associated with 92 SPSF procedures performed in 53 dogs and 20 cats, 
grouped by type of SPSF.
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Outcome
Overall, poor outcomes were recorded for 2 of the 
92 (2%) SPSF procedures, a fair outcome for 13 (14%), a 
good outcome for 33 (36%), and an excellent outcome for 
44 (48%). Poor, fair, good, and excellent outcomes were 
recorded for 2 (3%), 8 (12%), 25 (39%), and 29 (45%) of 
the 64 SPSFs performed in dogs and 0 (0%), 5 (18%), 8 
(29%), and 15 (54%) of the 28 SPSFs performed in cats.
Discussion
To the authors’ knowledge, the present study repre-
sented the first large retrospective study to characterize 
the indications, complications, and outcomes associated 
with different types of SPSFs performed for various rea-
sons in cats and dogs. The most common indications for 
the SPSF procedures were reconstruction of acute or 
chronic wounds and reconstruction of deficits created 
following tumor excision or scar revision, which were 
similar to those reported for axial pattern flaps7–9 and 
free-skin grafts.10–12 Previous studies of SPSF procedures 
have focused solely on dogs and cats undergoing tumor 
excision, so it was interesting to note the higher compli-
cation rate for SPSFs used to reconstruct acute or chronic 
wounds, compared with the rate for SPSFs used to recon-
struct a tumor excision deficit or a scar revision deficit 
in the present study. This difference in rates had several 
possible explanations. Open wounds are generally more 
difficult to clean and prepare for aseptic surgery than in-
tact skin. Chronic wounds may also have a change in skin 
flora that could alter wound healing.13–15 However, in the 
present study, clinical signs of postoperative infection 
were reported for only 8 animals, 3 of which received 
SPSFs to reconstruct a tumor excision deficit rather than 
to reconstruct an acute or chronic wound. Another pos-
sibility was that differences in wound perfusion existed 
or were created during flap elevation for open wounds 
versus surgically created wounds. It was also likely that 
the local environment surrounding an open wound (im-
portant for wound healing) was more inflamed, even if 
the wound had been managed well to create a healthy 
granulation wound bed prior to reconstruction surgery, 
than that surrounding surgically created wounds.
Fifty-one percent of the SPSFs performed in dogs 
and cats of the study reported here were associated 
with a minor or major complication, which was lower 
than the 89% complication rate reported for a large ret-
rospective case series7 of axial pattern flap procedures 
and comparable to the 50% complication rate reported 
for a large retrospective case series10 of free-skin graft 
procedures in dogs and cats. The most common com-
plication (30%) of SPSF procedures in both species of 
our study was dehiscence of the distal wound edge, 
which is also the most common complication reported 
for axial pattern flaps.7–9,16,17 Distal SPSF dehiscence is 
often due to excessive tension on the sutures. Excessive 
tension can also reduce the lumen size of capillaries in 
the flap, leading to partial necrosis.18
Partial flap necrosis was reported as a complication 
separate from dehiscence in the present study, noted for 
10% of the SPSFs. In certain instances, it may be better to 
create 2 smaller SPSFs rather than 1 larger SPSF to ensure 
that the flap base is appropriately wide for the flap length 
it is supporting and to reduce tension on the flap.18 De-
spite the 51% overall complication rate, only 14% of SPSF 
procedures were classified as having a major complica-
tion that resulted in > 50% flap failure or required further 
surgery. The mean time to onset of clinical signs of an 
SPSF complication was 6.9 days, suggesting that owners 
of dogs or cats that are discharged from the hospital be-
fore this time should be given detailed instructions re-
garding postoperative care, including a description of the 
 Total complications Minor complication Major complication
Indication for SPSF (n = 47) (n = 34) (n = 13)
Acute wound (n = 14) 9 (64) 7 (50) 2 (14)
Chronic wound (n = 28) 20 (71) 13 (46) 7 (25)
Tumor excision (n = 37) 11 (30) 9 (24) 2 (5)
Tumor scar revision (n = 7) 5 (71) 3 (43) 2 (29)
Other reason (n = 6) 2 (33) 2 (33) 0 (0)
See Table 1 for key.
Table 2—Complications associated with the SPSF procedures of Table 1, grouped by indication 
for the SPSF.
 Total complications Minor complication Major complication 
Location of SPSF (n = 47) (n = 34) (n = 13)
Torso (n = 43) 22 (51) 16 (37) 6 (14)
Proximal aspect of a limb (n = 29) 20 (69) 14 (48) 6 (21)
Head or face (n = 18) 3 (17) 3 (17) 0 (0)
Distal aspect of a limb (n = 2) 2 (100) 1 (50) 1 (50)
See Table 1 for key.
Table 3—Complications associated with the SPSF procedures of Table 1, grouped by location of 
the SPSF.
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signs of possible complications and indicating the poten-
tial need to return if a complication arises.
Subdermal plexus skin flaps used on the head or face 
were associated with a lower rate of complications than 
those used on the proximal aspect of a limb or on the 
torso in the study reported here. This finding differed 
from the results of the aforementioned retrospective 
study7 of axial pattern flap procedures in which location 
of the wound deficit was not identified as an independent 
risk factor for complications, whereas 4 of the 5 SPSFs 
that were used to cover deficits on the limbs in a smaller 
study5 involving 15 SPSF procedures failed to achieve 
100% viability. The head region has an excellent blood 
supply, and it may be easier to prevent patients from 
interfering with wounds in this area versus other areas 
such as the limbs. Usually, plenty of loose neck skin is 
available to reduce tension on an SPSF used on the head. 
We expected that SPSFs used to reconstruct limb deficits 
might have a higher complication rate than SPSFs used to 
reconstruct torso deficits because in our experience, the 
torso has more loose skin available (reducing SPSF ten-
sion) than the limbs; however, SPSFs used to cover proxi-
mal limb deficits originate from the torso. Skin deficits on 
the distal portion of a limb require use of a distant SPSF, 
of which only 2 were performed in the present study and 
therefore were not included in statistical comparisons, 
although both procedures were associated with compli-
cations. The skin over the limbs has different characteris-
tics than the skin over the torso, so the healing of a torso 
skin graft over a limb deficit might require more reorga-
nization during the healing process.18
A large proportion (48%) of SPSFs in the present 
study were associated with an excellent outcome, 
meaning no complications were noted and they 
healed successfully. A good outcome was achieved 
for another 36% of SPSFs, which healed successfully 
with minor interventions. The combined rate of good 
to excellent outcomes (84%) compared favorably 
with the rate reported for axial pattern flaps (64%)7 
and free skin grafts (77% success for cats and 38% for 
dogs).10 Therefore, our results supported the use of 
an SPSF whenever a choice exists between use of an 
SPSF and a more advanced reconstructive technique, 
such as use of axial pattern flaps or free skin grafts. 
Subdermal plexus skin flaps are simple to perform 
and are often chosen as a first-line reconstructive 
option, regardless of the experience of the veterinar-
ian performing the surgery. Furthermore, use of an 
SPSF would not usually preclude the use of a more 
advanced reconstructive technique at a later date.
Advancement and transposition SPSF procedures 
appeared to result in fewer complications than other 
types of SPSF procedures in the study reported here, 
although it was not possible to test this suggestion 
statistically given the available data. These types of 
SPSFs may have represented smaller or simpler wound 
reconstructions than the skin fold flaps and larger 
rotation flaps. One very large rotation flap described 
in a case report19 received negative-pressure wound 
therapy after surgery, which was deemed helpful in 
maintaining distal flap viability in the affected dog. 
Skin graft augmentation through the use of negative-
pressure wound therapy is also believed to improve 
graft survival.20,21 Locally injected platelet-rich plasma 
also reportedly increased tissue perfusion and viability 
of long abdominal wall SPSFs created in an experimen-
tal study22 involving 6 Beagles.
No difference in overall complication rate was 
identified between dogs and cats receiving an SPSF 
in the present study. In the authors’ experience, cats 
often have more loose skin available than certain 
breeds of dog; thus, the observed lack of a difference 
may have been attributable to the surgeons having 
planned ahead and taken into consideration the skin 
available in an individual animal such that they har-
vested only an appropriately sized flap to reconstruct 
a particular skin deficit.
The present study had important limitations that 
warrant consideration. Because of the study’s retrospec-
tive nature, the sample size and completeness and types 
of data collected could not be controlled, and fewer 
cats than dogs were included. The surgeries, although 
conducted at the same institution, were performed by 
multiple surgeons. Additionally, patients can differ in 
the amount of loose skin that can be used for SPSFs as 
well as in terminal blood supply and innervation pat-
terns, and each SPSF is ultimately formed on a case- 
by-case basis. Multi-institutional prospective studies are 
therefore recommended, and future research on this 
topic should include clearly defined surgical guidelines, 
measurements and photographs of the skin defect, mea-
surements of the flap base and length, estimation of the 
amount of flap tapering toward the leading edge, and 
measurement and photographs of the areas of dehis-
cence left to heal by second intention.
Despite any limitations, findings of the present 
study suggested that approximately half of SPSF pro-
cedures in dogs and cats can be expected to result in 
a postoperative complication, particularly if the SPSF 
is used to close a wound or the skin deficit is on the 
torso or a limb. Complications may be expected to be 
noted a mean of 1 week after surgery; however, with 
appropriate management, a good to excellent outcome 
appears possible. Owners should be counseled about 
the likely need for additional visits and costs associated 
with treatment of postoperative complications.
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Pharmacokinetics of levofloxacin following oral administration  
of a generic levofloxacin tablet and intravenous administration to dogs
Melanie Madsen et al 
OBJECTIVE
To determine the pharmacokinetics of levofloxacin following oral administration of a generic levofloxacin 
tablet and IV administration to dogs and whether the achieved plasma levofloxacin concentration would be 
sufficient to treat susceptible bacterial infections.
ANIMALS
6 healthy adult Beagles.
PROCEDURES
Levofloxacin was administered orally as a generic 250-mg tablet (mean dose, 23.7 mg/kg) or IV as a solution 
(15 mg/kg) to each dog in a crossover study design, with treatments separated by a minimum 2-day washout 
period. Blood samples were collected at various points for measurement of plasma levofloxacin concentra-
tion via high-pressure liquid chromatography. Pharmacokinetic analysis was performed with compartmental 
modeling.
RESULTS
After oral administration of the levofloxacin tablet, mean (coefficient of variation) peak plasma concentra-
tion was 15.5 µg/mL (23.8%), mean elimination half-life was 5.84 hours (20.0%), and mean bioavailability was 
104% (29.0%). After IV administration, mean elimination half-life (coefficient of variation) was 6.23 hours 
(14.7%), systemic clearance was 145.0 mL/kg/h (22.2%), and volume of distribution was 1.19 L/kg (17.1%).
CONCLUSIONS AND CLINICAL RELEVANCE
In these dogs, levofloxacin was well absorbed when administered orally, and a dose of approximately 25 mg/
kg was sufficient to reach pharmacokinetic-pharmacodynamic targets for treating infections with suscep-
tible Enterobacteriaceae (ie, ≤ 0.5 µg/mL) or Pseudomonas aeruginosa (ie, ≤ 1 µg/mL) according to clinical 
breakpoints established by the Clinical and Laboratory Standards Institute. (Am J Vet Res 2019;80:957–962)
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